Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine
Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine
The aim of the non-interventional study is to document the daily doses in acute and remission therapy, the frequence of doses (1, 2, 3 or 4 times daily), when rectal dosage forms are added and, when and how long steroids are given.
Inclusion Criteria:
Exclusion Criteria:
Merzig-Schwemmlingen, Germany
Pohlheim, Germany